Learn how you can find your next discovery at US HUPO 2023

Maximize target selection and validation with high-plex, high-throughput profiling of 7,000 proteins from a 55-μL sample.

Find the discovery you seek

See us in person at US HUPO 2023 – Booth 111 – from March 4-8 in Chicago.
Experience the power of 7,000 proteins and the SomaScan® Assay!

We look forward to showing you how high-plex proteomics with the pioneering SomaScan Platform can help you find that elusive target or pathway you’re looking for.

Not attending? Or want to know more today? Contact us!

Benoit Lehallier, PhD

SPONSORED BREAKFAST SEMINAR

Deep proteomics foundations for the next generation of transformational therapies

Tuesday, March 7, 2023 | 7:00-7:55 a.m.

Presenter: Benoit Lehallier, PhD
Senior Director of Data Science, Alkahest, Inc.

Join us Tuesday morning for an in-depth discussion on the potential of deep plasma proteomics analysis to develop the next generation of transformational therapies and the need for strong technical foundations to properly comprehend its complexity.

US HUPO 2023 poster sessions

Download our HUPO 2023 Poster Session Postcard for quick reference.
Visit this page after the sessions to view the posters online.

Date and Time Session Title Presenter
Monday, March 6
9:00 – 10:00 AM
P9.07: Efficient development of certified prognostic laboratory developed tests using proteomic data.
View poster >
Yolanda Hagar, PhD
Associate Director, Bioinformatics
Monday, March 6
10:00 – 11:30 AM
P8.09: Outcome variance between sample normalization methods Dylan Maxwell
Analyst II, Bioinformatics
Monday, March 6
10:00 – 11:30 AM
P12.05: Identifying genetic and environmental factors on proteins in age and cardiovascular risk using SomaScan
View poster >
Brendan Epstein, PhD
Scientist I, Bioinformatics
Monday, March 6
10:00 – 11:30 AM
P15.05: Utility of proteomic trajectories of cardiovascular risk and cardiorespiratory fitness to monitor adverse health states
throughout post-COVID-19
View poster >
Michael Hinterberg, PhD
Senior Scientist, Bioinformatics
Tuesday, March 7
9:00 – 10:00 AM
P9.06: Prognostic proteomic models for low event rates:
A case study with myocardial infarction.
View poster >
Yolanda Hagar, PhD
Associate Director, Bioinformatics
Tuesday, March 7
10:00 – 11:30 AM
P8.16: Topic modeling the human plasma proteome:
An unsupervised learning method for proteomic analysis
Blake Williams
Analyst III, Bioinformatics
Tuesday, March 7
10:00 – 11:30 AM
P8.06: SomaScan platform confirmation and performance validation
View poster >
Ted Johnson
Scientist I, Bioinformatics

Enhance your data by adding the SomaScan Platform to your mass spectrometry research

Published findings show the benefit of using complementary technologies to enhance your ability to:

  • Discover new biomarkers
  • See causal links
  • Identify new drug targets
  • Find new uses for already approved therapeutics

Image of SomaScan Assay video detailing how the Assay works

What could you find, if you could see your data in new ways?

Learn more
Talk to us today

Want a quick look at how the SomaScan Assay works?

Our Slow Off-Rate Modified Aptamers (called SOMAmer® reagents) are custom-engineered to have exquisite shape complementarity to their protein targets. Put them into action with a single, 55-μL sample.

 

Accelerate your research,
or generate revenue as a service provider

Learn how you can run the SomaScan Assay within your own lab. As a SomaLogic certified site, you will not only receive the benefits of analyzing your samples in-house, but can also accelerate your workflow, automate your processes, and unlock revenue-generating capabilities. And our expert support team will assist you every step of the way.

Thumbnail image of Dr Richard Head from Washington Medical University

Hear how Washington University uses complementary technologies in their own lab for greater efficiency and deeper insights.

Watch now